Trials / Completed
CompletedNCT02184234
Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)
A 6-week, Open, Multicentre Safety Trial to Evaluate the Tolerability Profile of Antistax® Film Coated Tablets (Extr. Vitis Viniferae Siccum), 360 mg/Day Per os, in Male and Female Patients Suffering From Chronic Venous Insufficiency
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Main objective: Safety and tolerability of Antistax® film coated tablets Secondary objective: Effect of Antistax® film coated tablets on subjective symptoms of chronic venous insufficiency
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antistax film coated tablets |
Timeline
- Start date
- 2001-06-01
- Primary completion
- 2001-10-01
- First posted
- 2014-07-09
- Last updated
- 2014-07-14
Source: ClinicalTrials.gov record NCT02184234. Inclusion in this directory is not an endorsement.